277 related articles for article (PubMed ID: 17258305)
1. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.
Leguy-Seguin V; Jolimoy G; Coudert B; Pernot C; Dalac S; Vabres P; Collet E
J Allergy Clin Immunol; 2007 Mar; 119(3):726-30. PubMed ID: 17258305
[TBL] [Abstract][Full Text] [Related]
2. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
Pagani M; Bonadonna P; Senna GE; Antico A
Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
[TBL] [Abstract][Full Text] [Related]
3. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy.
Caiado J; Venemalm L; Pereira-Santos MC; Costa L; Barbosa MP; Castells M
J Allergy Clin Immunol Pract; 2013; 1(5):494-500. PubMed ID: 24565621
[TBL] [Abstract][Full Text] [Related]
5. Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?
Elligers KT; Davies M; Sanchis D; Ferencz T; Saif MW
JOP; 2008 Mar; 9(2):197-202. PubMed ID: 18326929
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.
Enrique E; Malek T; Castelló JV; de Mateo JA
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):86. PubMed ID: 18254488
[No Abstract] [Full Text] [Related]
7. Occupational hypersensitivity to metal salts, including platinum, in the secondary industry.
Cristaudo A; Sera F; Severino V; De Rocco M; Di Lella E; Picardo M
Allergy; 2005 Feb; 60(2):159-64. PubMed ID: 15647035
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
9. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.
Markman M; Zanotti K; Peterson G; Kulp B; Webster K; Belinson J
J Clin Oncol; 2003 Dec; 21(24):4611-4. PubMed ID: 14673050
[TBL] [Abstract][Full Text] [Related]
10. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study.
Brockow K; Romano A; Aberer W; Bircher AJ; Barbaud A; Bonadonna P; Faria E; Kanny G; Lerch M; Pichler WJ; Ring J; Rodrigues Cernadas J; Tomaz E; Demoly P; Christiansen C;
Allergy; 2009 Feb; 64(2):234-41. PubMed ID: 19178403
[TBL] [Abstract][Full Text] [Related]
11. Skin testing in delayed reactions to drugs.
Barbaud A
Immunol Allergy Clin North Am; 2009 Aug; 29(3):517-35. PubMed ID: 19563995
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.
Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML
J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
Lee C; Gianos M; Klaustermeyer WB
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
[TBL] [Abstract][Full Text] [Related]
15. An experimental biological test to diagnose hypersensitivity reactions to carboplatin: new horizons for an old problem.
Pagani M; Venemalm L; Bonnadona P; Vescovi PP; Botelho C; Cernadas JR
Jpn J Clin Oncol; 2012 Apr; 42(4):347-50. PubMed ID: 22333049
[TBL] [Abstract][Full Text] [Related]
16. Allergic skin disease: investigation of both immediate- and delayed-type hypersensitivity is essential.
Usmani N; Wilkinson SM
Clin Exp Allergy; 2007 Oct; 37(10):1541-6. PubMed ID: 17883733
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service.
Capelle H; Tummino C; Greillier L; Gouitaa M; Birnbaum J; Ausias N; Barlesi F; Montana M
J Clin Pharm Ther; 2018 Jun; 43(3):320-326. PubMed ID: 29092096
[TBL] [Abstract][Full Text] [Related]
18. Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media.
Vernassiere C; Trechot P; Commun N; Schmutz JL; Barbaud A
Contact Dermatitis; 2004 Jun; 50(6):359-66. PubMed ID: 15274727
[TBL] [Abstract][Full Text] [Related]
19. Low Cross-Reactivity Between Cisplatin and Other Platinum Salts.
Pasteur J; Favier L; Pernot C; Guerriaud M; Bernigaud C; Lepage C; Jouve JL; Isambert N; Collet E
J Allergy Clin Immunol Pract; 2019; 7(6):1894-1900. PubMed ID: 30776524
[TBL] [Abstract][Full Text] [Related]
20. Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.
McAlpine JN; Kelly MG; O'malley DM; Azodi M; Coombe K; Schwartz PE; Rutherford TJ
Gynecol Oncol; 2006 Oct; 103(1):288-92. PubMed ID: 16647749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
